LexaGene: LexaGene : Proposes to Amend Warrants Terms - Form 8-K

(marketscreener.com) LexaGene Holdings Proposes to Amend Warrants Terms BEVERLY, Mass. USA - Dec 7, 2022 - LexaGene Holdings, Inc., , an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automated, genetic testing, announces that it intends to amend the exercise price of certain common share purchase...https://www.marketscreener.com/quote/stock/LEXAGENE-HOLDINGS-INC-49479172/news/LexaGene-Proposes-to-Amend-Warrants-Terms-Form-8-K-42495701/?utm_medium=RSS&utm_content=20221207